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1. Introduction 
A liver biopsy is a procedure where a small piece of liver tissue or liver cells are removed for 
microscopic examination. Taking a liver biopsy specimen for a microscopic examination can 
be performed in two ways: blind and guided liver biopsy. 
2.1 Blind biopsy 
The first, most common type of biopsy is a core-needle, blind biopsy.  
In this procedure a small piece of liver tissue is taken from the organ with the use of needle 
which diameter is 1.2 - 1.6 mm. The principle of this procedure is that the morphology of the 
liver specimen is the same as the morphology of whole organ. The size of the tissue sample 
taken from the liver enables the pathologist to evaluate the cell composition and to describe 
the location of particular cells in relation to other cells.  
Indications for a core-needle liver biopsy are presented in Table1.  
A core-biopsy can be performed as: a percutaneous core -needle biopsy, a transvenous 
(transjugular) core-needle biopsy, laparoscopic liver biopsy,  open wedge (surgical) biopsy.  
2.1.1 A percutaneous core -needle biopsy 
This type of biopsy is the most frequent. Indications are presented in Table 1. Percutaneous 
core-needle biopsy can be performed relatively easy. It can be performed in local anesthesia 
with the use of basic equipment.  
2.1.2 A transvenous (transjugular) core-needle biopsy 
This technique of performing a liver biopsy is indicated in patients with the increased risk of 
bleeding (e.g. thrombocytopenia), since in case of bleeding from biopsy site, liver blood 
directly flows to the lumen of hepatic vein and therefore it does not cause a subcapsular 
hematoma or bleeding into body cavities. However, the transvenous biopsy is a more 
invasive technique than the percutaneous biopsy.  It requires technical resources (imaging 
equipment) and is more expensive. 
2.1.3 Laparoscopic liver biopsy 
The laparoscopic surgery in the upper abdomen enables to take a liver tissue for 
pathological examination. However, the necessity to make a liver biopsy is hardly ever an 
indication for performing a laparoscopic surgery. Liver biopsy made with the use of this 
technique most frequently accompanies other medical procedures (e.g. cholecystectomy). 
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Disease entity Reason for performing biopsy Comments 
Chronic viral hepatitis B 
and C 
1. Confirmation of clinical diagnosis 
2. Assessment of grading of 
inflammation and staging of fibrosis 
In many cases – 
necessary to qualify a 
patient for antiviral 
treatment 
Alcoholic hepatitis 
Non-alcoholic fatty liver 
disease 
Autoimmune hepatitis 
1. Confirmation of clinical diagnosis 
2. Assessment of progression of 
disease 
Most often it serves as a 
tool for differential 
diagnosis 
Hemochromatosis 1.Setting a diagnosis 
2. Quantitative evaluation of liver iron 
level 
 
Wilson’s disease 
Primary biliary cirrhosis 
1. Confirmation of clinical diagnosis 
2. Assessment of progression of 
disease 
 
Primary sclerosing 
cholangitis 
1.Setting a diagnosis 
2. Differential diagnosis of cholestasis
Liver biopsy is 
indicated when 
diagnosis is not 
possible on the basis of 
imaging 
Drug-induced  liver disease
1. Confirmation of clinical diagnosis 
2. Assessment of progression of 
disease 
 
Evaluation of transplanted 
liver in a recipient 
1. Diagnosis of  acute or chronic 
transplant rejection 
2. Post – transplant viral hepatitis 
 
Fever of unknown origin 1.Setting a diagnosis  
Anomalous levels of liver 
enzymes of unknown 
origin 
1.Setting a diagnosis  
Table 1. Indications for a core-needle blind liver biopsy  
2.1.4 Open wedge (surgical) liver biopsy 
A small piece of subcapsular liver tissue can be obtained during laparotomy.  
The piece of tissue taken during open surgery is usually bigger than the specimen taken 
percutaneously. However, the tissue is often damaged due to the technique of excision and 
handling of specimen during surgery. Moreover the subcapsular specimen may not be fully 
representative for morphology of liver diease. 
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2.2 Guided liver biopsy 
The second type of biopsy is a core-needle or fine-needle-aspiration biopsy. 
Guided biopsy is aimed at diagnostics of focal lesions in liver and must be performed under 
visual control. In most cases ultrasonography is used for this purpose. Computed 
tomography is used less frequently.   
The use of a fine needle allows for aspiration of liver cells only. The obtained biological 
material consists of liver cell which are not bound to each other and immersed in liquid 
material. This type of biopsy is used for diagnostics of  focal changes in liver – filled with 
liquid or hypoechogenic (e.g. cysts). 
However, for diagnostics of solid focal changes in liver (tumour metastasis, hepato-cellular 
carcinoma) core needle biopsy is recommended. This technique allows for obtaining a 
tumour tissue, which considerably facilitates setting a diagnosis. 
3. A place of liver biopsy in diagnostic workup in liver disease 
It should be underlined that a decision to make a biopsy is one of the last steps taken in 
diagnostics of liver diseases.  In view of the fact that the method is invasive and has its 
limitations, it should be performed only when it is supposed to provide information 
necessary for treatment of the patient. Below there is a list of information about the patient 
and additional examinations which should be  made before taking a decision of performing 
a biopsy. 
3.1 Hepatological diagnostics before taking a liver biopsy 
Before performing a biopsy one should try to establish the cause of the liver disease on the 
basis of non-invasive examinations so as to gather as much information as possible for the 
pathologist examining the specimen referring to etiology, progression of the liver disease.  
Following tests should be made in each patient: 
 blood cell count (pancytopenia might imply portal hypertension) 
 biochemical (ALT, AST, ALP, GTP, bilirubin), indicating the presence of hepatocyte 
necrosis and cholestasis 
 viral markers (anti-HAV IgM, HBsAg, HBeAg, anti-HBc-total, anti-HCV, anti-delta) 
 molecular examinations – depending on the results received above. (HBV-DNA 
quantitatively, HCV-RNA quantitatively) 
 antibody analysis (ANA, AMA, ASMA, anti-LKM, anti-SLA) 
 proteinogram 
 in justified cases – examination for presence of Wilson’s disease (plasma ceruloplasmin 
level, plasma copper level, copper excretion via urine), hemochromatosis (plasma 
ferritin level, plasma iron level, possibly analysis of mutation of C282Y and H63D 
genes) 
 ultrasonography examination of a liver and evaluation with the use of Doppler analysis 
of potential presence of portal hypertension 
The age of the patient is often a determining factor as for the decision about performing a 
liver biopsy and the way in which it should be performed. In case of children and young 
adults (younger than 16 years old) parents often do not give consent to a liver biopsy and 
they demand less invasive diagnostic methods. Moreover, children who are subjected to a 
percutaneous biopsy, should undergo a short-term general anesthesia.  In the case of elderly 
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patients the doctor should decide whether the information gathered after taking a liver 
biopsy specimen will considerably influence further treatment.  For example: elderly 
patients suffering from chronic hepatitis C very often have numerous contraindications for 
interferon and ribavirin therapy. Therefore, a liver biopsy as a tool for qualification to 
antiviral treatment is useless in this setting.   
A free consent to liver biopsy. 
In every case the written consent for the procedure should be obtained from the patient or 
his committee. The patient should achieve complete information about indications for the 
procedure, diagnostic benefits and potential complications.   
Cooperation of the patient is a crucial element qualifying him for liver biopsy. 
The procedure performed in local anesthesia involves inserting a needle when the patient 
has exhaled the air. Inhaling or moving the body when the doctor inserts a needle might 
lead to liver rupture and massive hemorrhage. The patient must be informed about such 
possibility and should be taught to control his breathing. If, in the doctor’s opinion, it is not 
possible (small children, patients with mental or behavioral disorders), the patient should be 
given short-term general anesthesia. Otherwise the procedure should be abandoned. 
Moreover, the patient is then asked to stay in bed for 3 hours following the procedure.   
Body mass (BMI). In obese patients (>30 BMI) it might be difficult to take a liver biopsy 
specimen percutaneously because of thick subcutaneous fatty tissue.  
Concomitant diseases (e.g. circulatory insufficiency, scoliosis) might hamper performing  
a liver biopsy as it might be difficult to put the patient in the appropriate position and  
make him stay in that position for more than 10 minutes. Those suffering from hemophilia 
are usually disqualified from this kind of procedure because of the increased risk of 
bleeding. 
Allergy to medicaments used for local anesthesia (e.g. lidocaine) might  make the 
percutaneous biopsy impossible to perform. 
The information on medicaments taken by the patient for a longer period, especially 
anticoagulant medications (salicylic acid, acenocumarol) is crucial when the liver biopsy is 
planned. Patient should stop taking salicylic acid for one week before the liver biopsy. 
Administering of acenocumarol should be stopped two days before the liver biopsy. If it is 
not possible the doctor should perform transvenous biopsy or should not perform the 
biopsy at all. 
Menstrual cycle phase should be considered in female patients. Biopsy should not be made 
during menstruation (1 – 5 day) because of the increased risk of liver bleeding. 
4. Answers a liver biopsy can give 
 In majority cases of acute viral hepatitis liver biopsy is not performed. The diagnosis 
can be set on the base of biochemical and serologic examinations. The exceptions are the 
patients in whom on the base of other examinations and anamnesis it is not possible to 
determine whether they suffer from chronic or acute hepatitis. Since 
pathomorphological findings in these two kinds of hepatitis are different, liver biopsy 
might be helpful in setting the right  diagnosis and qualifying for treatment. It is 
important as the treatment of these diseases differ a lot.  
 In case of chronic viral hepatitis B and C morphological evaluation of a liver biopsy 
specimen helps to assess the grade and stage of the diasease (according to one of 
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assessment scales). In routine diagnostics the pathological examination of specimen 
does not help to discover etiology. The results of assessment of grade of inflammation 
and stage of fibrosis serve as a tool for qualification for treatment. Besides, 
morphological analysis facilitates diagnosing other liver diseases which accompany 
viral hepatitis (fatty liver disease, alcoholic liver disease, autoimmune hepatitis).  
Morphological analysis also helps to evaluate remission of changes after antiviral 
treatment.  
 Alcoholic liver disease (ALD) can be diagnosed without an analysis of the specimen in 
most cases. In any doubts, biopsy helps to set the right diagnosis, evaluate the fibrosis 
and presence of other inflammatory processes (e.g. AIH). 
 Biopsy specimen analysis is crucial in the case of non-alcoholic fatty liver disease 
(NAFLD) since additional analysis (biochemical and serologic) allow to exclude 
existence of other liver diseases. Morphological analysis helps to differentiate NAFLD 
and non-alcoholic steatohepatitis (NASH), evaluate accumulation of fat in hepatocytes  
in Dixon’s scale as well as consequences of the disease manifested by progression of 
fibrosis.  
 Suspicion of the presence of autoimmune hepatitis (AIH) is an indication for liver 
biopsy.  Morphological analysis helps to set a diagnosis in the case of unclear results of 
autoantibodies, differentiate e.g. AIH and ALD and evaluate the progression of the 
disease and its consequences – fibrosis and cirrhosis. Morphological analysis also 
proves how effective the applied treatment is.  
 Diagnosing liver metabolic diseases  (Wilson’s disease, hemochromatosis) without 
morphological analysis might be impossible to do. Morphological analysis not only 
enables to set the right diagnosis and differentiate with other liver diseases but also 
helps to make a quantitative evaluation of iron in the liver biopsy specimen, which is 
significant for further therapy. 
5. Answers a liver biopsy cannot give 
Liver biopsy should not be made: 
 if the diagnosis can be established with the use of non-invasive methods, 
 if the information gathered does not change decisions as for the therapy, 
 if biopsy might be a health hazard. 
Therefore, the biopsy should not be performed in patients with decompensated liver 
cirrhosis. When the clinical diagnosis is obvious (ascites, oedema, jaundice, symptoms of 
portal hypertension) the liver biopsy will not give more diagnostic information and will 
not influence on the choice of treatment method. Besides, in the case of hemorrhagic 
diathesis which accompanies cirrhosis, the liver biopsy may lead to hemorrhage. As 
medical practice shows, in patients suffering from cirrhosis, it is difficult or even 
impossible to obtain a representative liver biopsy specimen. Moreover, the specimen is 
often small and dismembered, which makes the pathologic examination almost 
impossible. 
6. Diagnostic workup before commencing a liver biopsy 
Set of tests which should be performed during last 24 hours before core biopsy is presented 
in Table 2.  
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Analysis Comments
Blood cell count 
The number of platelets should exceed 
60,000/µl, to avoid bleeding 
Blood group 
Identifying blood group before the biopsy 
allows for faster blood transfusion in the 
event of possible hemorrhage 
Coagulogical analysis 
Prothrombin time should not exceed the 
reference value by more than 4 seconds 
(INR>1.4) 
Activated partial thromboplastic time 
(APTT) should not exceed the reference 
value by 1.5 times 
Image examination (e.g. USG, CT) Excluding focal lesions in the liver 
Table 2. Set of tests which should be made directly before blind liver biopsy. 
7. The choice of type of liver biopsy 
Focal changes discovered in ultrasound examination or computed tomography are 
indications for an image-controlled biopsy. 
In patient with chronic hepatitis in whom a solid focal change is diagnosed two USG-guided 
core biopsies should be made. The first specimen should be obtain from the solid lesion.  
The other should be obtained from other part of liver (with the avoidance of lesion  
volume).   
8. How to prepare a patient to liver biopsy 
On the day of biopsy the patients is advised to remain fast. He should be examined by the 
physician performing the procedure. Fever, cough, bleeding or circulatory insufficiency 
diagnosed prior to the biopsy should be temporary contraindications for it. Thirty minutes 
before the surgery the patient is sedated with 5 mg of diazepam administered 
intramuscularly. 
9. Anesthesia 
In adults and children who can cooperate during the procedure (usually above 15 years  
of age) liver biopsy is made in local anesthesia. To do it one should use 8-10 ml of 1% 
lidocaine solution. The technique of anesthesia is described below (Point 10). When the 
patient is not willing to cooperate, the procedure should be performed in short-term general 
anesthesia.  
10. Technique of core biopsy 
10.1 The position of the patient 
The patient should be in supine position, with his right upper limb placed behind the head, 
the left one – along the body. Intercostals spaces should be as wide as possible (middle 
armpit line should be in the shape of arch). 
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10.2 Determining the area of biopsy 
Upper and lower limits of liver dullness should be established with the use of percussion. 
Next, the physician should mark the area of biopsy in the intercostals space, in the middle of 
liver dullness, on the middle armpit line or anterior armpit line. 
10.3 Antiseptics 
After putting on sterile gloves the area of biopsy should be cleansed twice with antiseptic 
substance and the skin should be left to dry. 
10.4 Local anesthesia 
The anesthesia should be done in the place selected beforehand. Lidocaine solution should 
be injected subcutaneously and later on, the needle must be inserted deeper, inside the 
intercostals space, continuously injecting a solution. Once the needle touches the capsule the 
needle should be slowly withdrawn and the solution – administered.  
10.5 Liver biopsy 
After application of anesthetic, the assisting nurse opens a set for liver biopsy. It consists of a 
blockage controlled syringe, a biopsy needle, a hypodermic needle and a blade.  
The first activity involves putting a hypodermic needle for on the blockage controlled 
syringe and then aspiration of 4 ml of aseptic solution of isotonic salt in such a way that the 
“brake” in the syringe remains in the unblocked position. Next, the hypodermic needle 
should be taken off and replaced with the biopsy needle. The syringe with the biopsy needle 
should be put aside in a sterile place and with the use of scalpel the doctor should make an 
incision – 2 to 3 mm long - in the intercostals space skin. Then the needle biopsy should be 
placed inside the incision as deep as to the liver capsule. At this moment the needle should 
be moved a few milimetres backwards. The patient should inhale air, exhale it to the end 
and then hold his breath. At the moment the patients does not breathe the doctor should 
inject about 2 ml of isotonic salt and then, pull the piston to block the “brake” and quickly 
move the needle in the direction of liver to the depth of about 3 cm and take it out 
immediately. After removing the needle from the intercostals space the patient should be 
allowed to breathe freely. With a sterile gauze pad one should press the area where the liver 
specimen has been taken since the skin might start bleeding a little. After putting a sterile 
dressing on the biopsy area the biopsy needle should be emptied , which should be done by 
unblocking the “brake” of the syringe. The content of the needle should be put in a prepared 
container with formalin solution. Then the doctor performing the biopsy should 
macroscopically evaluate the size of the taken specimen. If it is too small or dismembered 
too much, the procedure should be repeated.  
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